Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Serenity Health held its 4th annual Fentanyl Awareness Day event on Tuesday, April 29. Janice Thigpen is the first woman ...

FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...

Laryngeal cancer is a serious condition that can impact your ability to speak, swallow and in some cases, breathe. Each year, ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...